Alisa W Serio

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Methicillin Resistant Staphylococcus Aureus

Systematic Review

Top Venues

Antimicrobial agents and chemotherapy

Military medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Henry S Heine, George L Drusano, Bret K Purcell, Diane Anastasiou, S Ken Tanaka, Alisa W Serio
Omadacycline is active in vitro and in vivo against ciprofloxacin-resistant Bacillus anthracis . Antimicrobial agents and chemotherapy (2024)
Elisa H Ignatius, Binayak Rimal, Chandra M Panthi, Daniel C Belz, Christopher K Lippincott, Daniel H Deck, Alisa W Serio, Gyanu Lamichhane
Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease. mSphere 9 (7) (2024)
Elisa H Ignatius, Binayak Rimal, Chandra M Panthi, Daniel C Belz, Christopher K Lippincott, Daniel H Deck, Alisa W Serio, Gyanu Lamichhane
Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease. mSphere 9 (7) (2024)
Elisa H Ignatius, Binayak Rimal, Chandra M Panthi, Daniel C Belz, Christopher K Lippincott, Daniel H Deck, Alisa W Serio, Gyanu Lamichhane
Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease. mSphere 9 (7) (2024)
Elisa H Ignatius, Binayak Rimal, Chandra M Panthi, Daniel C Belz, Christopher K Lippincott, Daniel H Deck, Alisa W Serio, Gyanu Lamichhane
Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease. mSphere (2024)
Daniel V Zurawski, Alisa W Serio, Chad Black, Brandon Pybus, Kevin S Akers, Daniel H Deck, Sheila Johnson, Supaksorn Chattagul, Schroeder M Noble, Malik Raynor, Charlotte A Lanteri
A Review of Omadacycline for Potential Utility in the Military Health System for the Treatment of Wound Infections. Military medicine (2023)